Gio Gonzalez was named in the Biogenesis report. Then, reports James Wagner:
Gonzalez had blood and urine samples taken two days after the New Times report was published on Jan. 29, according to two people with knowledge of the situation.
Baseball is allowed to do “reasonable cause” testing. The Joint Drug Agreement says that can happen with two days’ notice. Don’t gotta be a rocket scientist to figure this one out.
In the event that there was a positive test it would be weeks or even a month or two before it was known.
The Dodgers announced on Thursday that the club activated pitcher Grant Dayton from the 10-day disabled list and designated pitcher Sergio Romo for assignment.
Dayton, 29, went on the disabled list earlier this month with neck stiffness. He’ll resume with a 3.63 ERA and a 20/12 K/BB ratio in 22 1/3 innings.
Romo, 34, signed a one-year, $3 million deal with the Dodgers in February. It didn’t really work out, as the right-hander posted a 6.12 ERA with a 31/12 K/BB ratio in 25 innings. His peripherals are still decent, so it wouldn’t be surprising if a team in need of a bullpen arm makes a deal with the Dodgers within the week.
MLB.com’s Jeffrey Flanagan reports that Royals pitcher Nate Karns underwent surgery for thoracic outlet syndrome on Wednesday. He’s expected to be ready for spring training next year. Karns went on the disabled list in May with an elbow injury and didn’t make much progress.
The Royals acquired Karns from the Mariners in January in exchange for outfielder Jarrod Dyson. Over eight starts and one relief appearance, the 29-year-old right-hander compiled a 4.17 ERA and a 51/13 K/BB ratio in 45 1/3 innings.
Karns will enter his first of three years of arbitration eligibility after the season, so he’ll be under the Royals’ control through 2020.